News & Opinion
Top 10 Innovations
Cell & Molecular Biology
Disease & Medicine
Ecology & Environment
Genetics & Genomics
Pharma & Biotech
Image of the Day
FDA Declares Kratom an Opioid. We’re Here to Explain What It Does.
Jim Daley | Feb 7, 2018
speaks with a clinical toxicologist to discuss how the supplement acts in the brain and what the agency's declaration means for research.
Biohacker Injects DIY Herpes Vaccine on Facebook Live
Shawna Williams | Feb 5, 2018
The stunt, performed at a biohacking conference, was purportedly part of a two-subject trial of the genetically modified vaccine.
Gilead’s CAR T-Cell Therapy Administered to Just Five Patients in Two Months
Catherine Offord | Dec 17, 2017
More than 200 people are on waiting lists for the $373,000 treatment as hospitals try to work around problems with insurers.
Foundation Medicine’s Cancer Gene Test Gains FDA and CMS Approval
Diana Kwon | Dec 1, 2017
The Centers for Medicare and Medicaid Services propose covering the test with Medicare.
The Rising Research Profile of 23andMe
Catherine Offord | Nov 30, 2017
An exploration of the genetics of earlobe attachment is just the latest collaborative research project to come out of the personal genetic testing company.
FDA Approves Second CAR T-Cell Therapy
Ashley P. Taylor | Oct 19, 2017
The therapy, produced by Kite Pharma and owned by Gilead Sciences, is approved for use against some types of large B-cell lymphomas.
Advisors to FDA Recommend Approval of Gene Therapy for Blindness
Jef Akst | Oct 12, 2017
Spark Therapeutics’s Luxturna would be the first approved therapy in the U.S. that replaces or repairs a defective gene inherited from one’s parents.
FDA Study Halted After Jane Goodall Objects
Bob Grant | Sep 26, 2017
The primatologist had written to the agency that the trial, which involved observing the effects of nicotine addiction in squirrel monkeys, was “cruel and unnecessary.”
Majority of Top Government Science Jobs Unfilled
Catherine Offord | Aug 31, 2017
Only 12 positions out of 44 have received nominations, and half of Trump’s nominees have strong ties to the industries they would oversee, a new report shows.
FDA Goes After Two Stem Cell Clinics
Kerry Grens | Aug 29, 2017
The agency raided one that was using a stem cell-smallpox vaccine combo, and sent a warning to another to obey best practices.